Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey

Mueller, JK; Ahrens, KF; Bauer, M; Baune, BT; Borgwardt, S; Deckert, J; Domschke, K; Ellwanger, R; Fallgatter, A; Frodl, T; Gallinat, J; Gottschalk, R; Grabe, HJ; Hasan, A; Herpertz, SC; Hurlemann, R; Jessen, F; Kambeitz, J; Kircher, T; Kornhuber, J; Lieb, K; Meyer-Lindenberg, A; Rupprecht, R; Scherbaum, N; Schlang, C; Schneider, A; Schomerus, G; Thoma, A; Unterecker, S; Walter, M; Walter, H; Reif, A; Reif-Leonhard, C

Mueller, JK (通讯作者)，Univ Hosp Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Heinrich Hoffmann Str 10, D-60528 Frankfurt, Germany.

PHARMACOPSYCHIATRY, 2023; 56 (6): 227

Abstract

Introduction In patients with a pre-existing mental disorder, an increased risk for a first manifestation of a psychiatric disorder in COVID-19 patien......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索